Latest Gene Therapy news
FDA Approves Breyanzi for Relapsed, Refractory Marginal Zone Lymphoma
posted December 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: Sustained Benefit Seen for Etranacogene Dezaparvovec in Hemophilia B
posted December 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Lentiviral Gene Therapy Shows Sustained Clinical Efficacy for ADA-SCID
posted October 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Exa-Cel Gene Therapy Improves Quality of Life in Severe Sickle Cell Disease
posted September 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome 
Subclinical Cardiac Dysfunction Linked to Neurodegeneration in APOE-ε4 Carriers 
Study IDs Dementia Risk Factors in Those Older Than 90 Years Related Articles
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer 
Revakinagene Taroretcel Reduces Ellipsoid Zone Area in Macular Telangiectasia Type 2 
Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa Monthly Specialist Briefings
Stay Connected
